Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.

Maagdenberg, Hedy

Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients. [electronic resource] - Pharmacogenomics 10 2018 - 1195-1202 p. digital

Publication Type: Journal Article

1744-8042

10.2217/pgs-2018-0095 doi


Adolescent
Age Factors
Anticoagulants--administration & dosage
Child
Child, Preschool
Cytochrome P-450 CYP2C9--genetics
Cytochrome P-450 CYP3A--genetics
Female
Follow-Up Studies
Genotype
Humans
Infant
Male
Pharmacogenetics--methods
Phenprocoumon--administration & dosage
Polymorphism, Single Nucleotide--genetics
Retrospective Studies
Vitamin K Epoxide Reductases--genetics